Novo Nordisk loses two senior staff to alternative antibiotics firm

Swiss biotech company Micreos Pharmaceuticals, which is developing alternatives to antibiotics, has succeeded in its hunt for new upper-level employees for two newly established roles, poaching two employees from Novo Nordisk.

Carsten Edwards and Trine Ahlgreen | Photo: Micreos Pharmaceuticals / PR

Swiss Micreos Pharmaceuticals, which develops new biological therapies against unwanted bacteria within a number of indications, has announced the hires for two new positions, chief business officer and chief development officer, a company press release reports.

Trine Ahlgreen and Carsten Edwards are both joining the firm from Novo Nordisk, where they have worked for 20 and four years, respectively.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs